10-Q: Concentra Reports Strong Revenue Growth Amid Strategic Acquisitions

Concentra Group Holdings Parent, Inc. reported significant revenue growth in Q2 2025, driven by strategic acquisitions, despite a decline in net income due to increased interest expenses and acquisition-related costs.

Summary

• Revenue increased 15.2% to $550.8 million for the three months ended June 30, 2025, and 11.2% to $1,051.5 million for the six months ended June 30, 2025, compared to the prior year periods.
• Total patient visits grew 9.5% in Q2 2025 and 5.6% year-to-date, primarily from workers compensation and employer services.
• Revenue per visit increased 4.4% in Q2 2025 and 5.0% year-to-date, driven by higher reimbursement rates and employer services rates.
• Net income attributable to the Company decreased to $44.6 million in Q2 2025 from $51.7 million in Q2 2024, and to $83.5 million year-to-date from $100.7 million.
• Basic and diluted EPS declined to $0.35 in Q2 2025 from $0.50 in Q2 2024, and to $0.65 year-to-date from $0.97.
• Adjusted EBITDA increased 13.2% to $115.0 million in Q2 2025 and 10.1% to $217.7 million year-to-date.
• Acquired Nova Medical Centers for $265.0 million in March 2025, adding 67 occupational health centers.
• Acquired Pivot Onsite Innovations for $54.4 million in June 2025, adding over 240 onsite health clinics.
• Cash balance decreased to $73.9 million at June 30, 2025, from $183.3 million at December 31, 2024, primarily due to acquisitions.
• Net cash provided by operating activities decreased to $100.1 million for the six months ended June 30, 2025, from $115.1 million in the prior year, due to increased interest payments.
• Long-term debt increased to $1,652.0 million at June 30, 2025, from $1,468.9 million at December 31, 2024, following new debt financing for acquisitions.
• The leverage ratio was 3.8x at June 30, 2025, well below the covenant of 6.50x.
• Declared and paid quarterly cash dividends of $0.0625 per share.

Sentiment

Score: 6

Explanation: While revenue and Adjusted EBITDA show strong growth, net income and EPS declined significantly due to increased interest expenses and acquisition costs. The company is actively expanding through acquisitions and managing debt, but the immediate impact on profitability is negative. Legal proceedings also present ongoing uncertainties.

Positives

• Strong revenue growth of 15.2% in Q2 2025 and 11.2% year-to-date, driven by increased patient visits and higher revenue per visit.
• Significant expansion of operations through strategic acquisitions of Nova Medical Centers (67 centers) and Pivot Onsite Innovations (over 240 onsite clinics).
• Adjusted EBITDA increased by 13.2% in Q2 2025 and 10.1% year-to-date, indicating improved operational profitability before certain non-operating expenses.
• Successful amendment of credit facilities, increasing the Revolving Credit Facility by $50.0 million to $450.0 million and adding $102.1 million in incremental term loan, while reducing interest rates.
• Leverage ratio of 3.8x is well within the covenant limit of 6.50x, indicating healthy debt management.
• Implementation of interest rate swap and collar contracts to mitigate exposure to variable interest rates on $600 million of debt.

Negatives

• Net income attributable to the Company decreased by 13.8% in Q2 2025 and 17.1% year-to-date, primarily due to significantly higher interest expenses and acquisition-related costs.
• Basic and diluted EPS declined by 30% in Q2 2025 and 33% year-to-date.
• Cash balance significantly decreased by $109.4 million from December 31, 2024, to June 30, 2025, largely due to cash used for acquisitions.
• Net cash provided by operating activities decreased by $15.0 million for the six months ended June 30, 2025, compared to the prior year, mainly due to increased interest payments.
• General and administrative expenses increased as a percentage of revenue due to acquisition and transition costs, one-time separation costs, stock compensation, and new personnel costs for standalone operations.

Risks

• The frequency of work-related injuries and illnesses.
• Adverse changes to relationships with employer customers, third-party payors, workers compensation provider networks, or employer services networks.
• Changes to regulations, new interpretations of existing regulations, or violations of regulations.
• State fee schedule changes undertaken by state workers compensation boards or commissions and other third-party payors.
• Ability to realize reimbursement increases at rates sufficient to keep pace with the inflation of costs.
• Labor shortages, increased employee turnover or costs, and union activity could significantly increase operating costs.
• Ability to compete effectively with other occupational health centers, onsite health clinics, and healthcare providers.
• Security breaches of information technology systems (company or third-party vendors) which may cause HIPAA violations and subject the company to potential legal and reputational harm.
• Negative publicity resulting in increased governmental and regulatory scrutiny and possibly adverse regulatory changes.
• Significant legal actions could subject the company to substantial uninsured liabilities.
• Litigation and other legal and regulatory proceedings in the course of business that could adversely affect the business and financial statements.
• Insurance coverage may not be sufficient to cover losses incurred.
• Acquisitions may use significant resources, may be unsuccessful, and could expose the company to unforeseen liabilities.
• Exposure to additional risk due to reliance on third parties in many aspects of the business.
• Compliance with applicable laws regarding the corporate practice of medicine and therapy and fee-splitting.
• Facilities are subject to extensive federal and state laws and regulations relating to the privacy of individually identifiable information.
• Compliance with applicable data interoperability and information blocking rules.
• Facility licensure requirements in some states are costly and time-consuming, limiting or delaying operations.
• Ability to adequately protect and enforce intellectual property and other proprietary rights.
• Adverse economic conditions in the U.S. or globally.
• Any negative impact on the global economy and capital markets resulting from other geopolitical tensions.
• Impact of impairment of goodwill and other intangible assets.
• Ability to maintain satisfactory credit ratings.
• Effects of the separation from Select Medical Corporation on the business.
• Ability to achieve expected benefits of and successfully execute the separation and related transactions.
• Restrictions on business, potential tax and indemnification liabilities, and substantial charges in connection with the separation and related transactions.
• Negative impact of public threats such as a global pandemic or widespread outbreak of an infectious disease.
• Loss of key members of the management team.
• Ability to attract and retain talented, highly skilled employees and a diverse workforce, and on the succession of senior management.
• Climate change, or legal, regulatory or market measures to address climate change.
• Increasing scrutiny and rapidly evolving expectations from stakeholders regarding ESG matters.
• Changes in tax laws or exposures to additional tax liabilities.
• Changes to United States tariff and import/export regulations and the impact on global economic conditions may have a negative effect on business, financial condition, and results of operations.

Future Outlook

The company intends to grow through strategic acquisitions of existing occupational health centers and onsite health clinic platforms, as well as building new de novo centers. The recently enacted One Big Beautiful Bill Act (OBBBA) is being assessed for its impact on financial statements, with certain provisions effective in 2025 and others through 2027.

Management Comments

• Management believes that the number of patient visits is the single most important indicator of the volume of services being provided in our centers.
• Our internally generated cash flows and borrowing capacity under our Revolving Credit Facility will allow us to finance our operations in both the short and long term.
• The declaration and payment of dividends in the future are at the discretion of our Board of Directors after taking into account various factors, including, but not limited to, our financial condition, operating results, available cash and current and anticipated cash needs, the terms of our indebtedness, and other factors our Board of Directors may deem to be relevant.

Industry Context

Concentra Group Holdings Parent, Inc. operates as the largest provider of occupational health services in the United States by number of locations, expanding its national presence through strategic acquisitions like Nova Medical Centers and Pivot Onsite Innovations. This expansion aligns with a trend towards integrated and comprehensive employer-focused health services, including workers compensation, employer services, and onsite clinics, aiming to capture a larger share of the corporate health market. The company's focus on increasing patient visits and revenue per visit, alongside managing labor costs, reflects common challenges and strategies in the labor-intensive healthcare industry.

Legal Proceedings

• California Department of Insurance Investigation: Subpoena received February 5, 2024, relating to an investigation under the California Insurance Frauds Prevention Act concerning billing and coding for physical therapy claims submitted to commercial insurers and workers compensation carriers in California. The company is cooperating but unable to predict the timing and outcome.
• Perry Johnson & Associates, Inc. (PJ&A) Data Breach: Notified on November 10, 2023, of a cybersecurity event affecting certain patient information. Notices sent to almost four million patients in February 2024. Six putative class action lawsuits were filed, consolidated in the U.S. District Court for the Eastern District of New York. A Consolidated Class Action Complaint was filed on August 19, 2024, alleging negligence, breach of contract, and statutory duty violations. An amended Direct-Filed Class Action Complaint was filed in March 2025. The company is working with its cybersecurity risk insurance policy carrier and does not believe the matter will have a material impact on operations or financial performance, but the timing and outcome are unpredictable.
• Physical Therapy Billing (DOJ Investigation and Qui Tam Lawsuit): U.S. Department of Justice (DOJ) and U.S. Department of Health and Human Services (HHS) are investigating potential False Claims Act violations related to billing for physical therapy services since October 7, 2021. A qui tam lawsuit was unsealed in May 2024, alleging billing for one-on-one therapy services when group therapy was performed, overbilling, and billing for unreimbursable unskilled services. Select's motion to dismiss the second amended complaint was granted in June 2025, allowing for a final amendment. A third amended complaint was filed in July 2025. The company is cooperating but unable to predict the timing and outcome.

Related Party Transactions

• Transition services agreement fees of $3.5 million for the three months ended June 30, 2025, and $7.2 million for the six months ended June 30, 2025, paid to Select Medical Corporation.
• Shared service fees from Select Medical Corporation of $3.8 million for the three months ended June 30, 2024, and $7.7 million for the six months ended June 30, 2024.
• Interest expense on related party debt with Select Medical Corporation was $9.3 million for the three months ended June 30, 2024, and $19.3 million for the six months ended June 30, 2024 (no expense in 2025 due to payoff).
• Distributions to Select Medical Corporation of $7.7 million for income tax adjustments for the six months ended June 30, 2024.
• Robert Ortenzio, Executive Chairman and director, through affiliated trusts, entered into a Rule 10b5-1(c) trading plan to sell up to 1.1 million shares of common stock.

Stakeholder Impact

• Shareholders: Impacted by declining net income and EPS despite revenue growth, increased debt, and ongoing dividend payments. The 10b5-1 trading plan by a key executive could signal future share price movements.
• Employees: Potential impact from integration of acquired companies (Nova, Pivot Onsite Innovations) and ongoing efforts to achieve staffing efficiencies.
• Customers (Employers): Benefit from expanded network of occupational health centers and onsite clinics, offering a broader range of services.
• Patients: Benefit from expanded access to occupational health services through new centers and clinics.
• Creditors: Affected by increased long-term debt, but mitigated by hedging strategies and a leverage ratio well within covenants.

Next Steps

• Complete final purchase price allocation for Nova and Pivot Onsite Innovations acquisitions within 12 months of closing dates.
• Assess the impact of the One Big Beautiful Bill Act (OBBBA) on financial statements.
• Continue to grow through strategic acquisitions and building new de novo centers.
• File a motion to dismiss the third amended complaint in the physical therapy billing lawsuit.
• Pay declared cash dividend of $0.0625 per share on August 28, 2025.

Key Dates

Recommendation

While Concentra demonstrates strong revenue growth and strategic expansion through acquisitions, the significant decline in net income and EPS due to increased interest expenses and acquisition-related costs is a concern. The company's operational efficiency (as seen in Adjusted EBITDA growth) is positive, and debt management appears sound with a healthy leverage ratio and hedging in place. However, the ongoing legal proceedings and the substantial cash outflow for acquisitions introduce uncertainty. A 'hold' recommendation is appropriate as the company navigates these integration and litigation challenges, with potential for future upside if acquisitions successfully drive profitability and legal risks are mitigated.

Keywords

Occupational Health, Healthcare Services, Workers Compensation, Onsite Clinics, Employer Services, Medical Centers, SEC Filing, 10-Q, Acquisitions, Financial Results, Debt Financing, Corporate Governance, Risk Management